Highest-materiality recent filing
UFP Technologies appoints Mitchell Rock as CEO, Ryan Stafford as General Counsel & SVP HR
Mitchell C. Rock appointed CEO and joins Board effective June 4, 2026.
UFP Technologies Q1 net income $17.5M, revenue up 4.1% to $154.2M
GAAP EPS $2.24, adjusted EPS $2.48; net income up 1.8% YoY from $17.2M.
UFP Technologies reports record 2025 sales of $602.8M, EPS $8.75
Net income $68.3M (+15.8% YoY); adjusted net income $76.1M (+12.7%).
UFP Technologies detects cyber incident; data exfiltrated, systems mostly restored
On Feb 14, 2026, UFP detected unauthorized access; third party removed and access restored in all material respects.
UFP Tech extends supply pact with Intuitive Surgical to 2029, boosts min volumes
Amendment No. 27 extends Manufacturing Supply Agreement term by two years, now through Dec 31, 2029.
UFP Technologies appoints Mitchell C. Rock as CEO effective June 4, 2026; base salary $700k
Mitchell C. Rock appointed CEO effective June 4, 2026; base salary $700k, annual bonus target up to 100% of base.
UFP Technologies CEO Bailly to retire June 2026; President Rock to succeed
R. Jeffrey Bailly will retire as CEO effective June 4, 2026, after 31 years as CEO.
UFP Technologies Q2 2025: Record net income $17.2M; sales up 37% YoY; completed two acquisitions
Net income of $17.2M ($2.21 diluted EPS) vs $13.6M ($1.75) in Q2 2024; adjusted EPS $2.50 (+27%).
UNIPEC acquired for $7.5M cash; ~3.75x adj. EBITDA; $5M revenue, $2M EBITDA.
UFP Technologies reports record Q1: revenue $148.1M (+41%), net income $17.2M (+35%), EPS $2.21
Net sales $148.1M vs $105.0M (+41.1%); MedTech sales up 50.4% to $135.4M.
AJR Enterprises subsidiary signs two exclusive supply agreements with Sage Products (Stryker) for manufacturing rights.
UFP Technologies reports record 2024 revenue of $504.4M, adj. EPS $8.68, up 31%
Full-year net income $59.0M (+31.3%); adjusted net income $67.6M (+32.5%); GAAP EPS $7.58, adj. EPS $8.68.
UFP Technologies Q3 net income up 40% to $16.4M, sales up 44% to $145.2M
Net income rose 40% to $16.4M vs $11.7M YoY; adjusted net income up 46.5% to $18.6M.
UFP Technologies acquires AQF Medical for €43M; 12.3x EBITDA multiple
Purchase price €43.0M cash; multiple ~12.3x adjusted EBITDA for 12 months ended June 30, 2024.
UFP Technologies Q2 net income $13.6M ($1.75 EPS), revenue up 10% to $110.2M; acquires three firms
Net income $13.6M ($1.75 diluted EPS) vs $11.9M ($1.55) in Q2 2023, up 14.0%.
UFP Technologies acquires AJR Enterprises for $110M; finances with new $275M credit facility
Purchase price $110M cash; AJR generated ~$75M sales and ~$18.3M adjusted EBITDA TTM ended Mar 31, 2024.
UFP Technologies Q1 net income up 30% to $12.7M; EPS $1.64; sales $105M (+7.4%)
Diluted EPS of $1.64 vs $1.27 in Q1 2023; net income $12.7M vs $9.7M.
Amended manufacturing supply agreement with Intuitive Surgical SARL, effective Jan 1, 2024, for a four-year initial term.
UFP Technologies reports record 2023; EPS up 7% to $5.83, sales +13.1%
FY2023 net sales $400.1M (+13.1% YoY); net income $44.9M ($5.83 diluted EPS) vs $41.8M ($5.45).
UFP Technologies Q3 adjusted net income up 13.8% to $11.9M; sales $100.8M
Sales Q3 $100.8M (+3.9% YoY); YTD $298.6M (+13.7%). Organic growth 5.6% in Q3.
UFP Technologies posts record Q2: net income $11.9M, EPS $1.55, sales $100M
Net income $11.9M ($1.55 diluted EPS) vs $8.9M ($1.17) in Q2 2022, up 34%.
UFP Technologies Q1 net income $9.7M ($1.27 EPS), revenue up 37% to $97.8M
Medical market sales surged 59.5% to $83.8M, led by 112% growth in robotic surgery.
UFP Technologies reports record 2022 revenue $353.8M, EPS $5.45 (+160% YoY)
Full-year 2022 revenue $353.8M (+71.5% YoY); net income $41.8M ($5.45 diluted EPS) vs $15.9M ($2.09) in 2021.
UFP Technologies reports record Q3: EPS $2.56 vs $0.50, sales up 91% to $97M
Net income $19.5M ($2.56 diluted EPS) vs $3.8M ($0.50) in Q3 2021; sales $97.0M, up 91.2% YoY.
Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies, Inc., a Delaware corporation (the “ Company ”), that he plans to retire from the Company after a period of transition.
On June 4, 2026, the Company announced that it had appointed Ryan Stafford as the Company’s General Counsel, Senior Vice President of Human Resources, and Secretary, effective June 4, 2026.
appointment of Mitchell C. Rock as the Company’s Chief Executive Officer
On May 19, 2026, Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies, Inc., a Delaware corporation (the “ Company ”), that he plans to retire from the Company after a period of transition .
On March 15, 2025, Steve Cardin, Vice President and Chief Operating Officer of the MedTech business of UFP Technologies, Inc., a Delaware corporation (the “Company”), tendered his resignation from the Company.
On February 6, 2024, the Board of Directors (the “Board”) of UFP Technologies, Inc. (the “Company”) appointed Mitchell C. Rock to President of the Company, effective immediately.
Effective as of December 31, 2021, Daniel J. Shaw, Jr., Vice President of Research and Development at UFP Technologies, Inc., a Delaware corporation (the “Company”), will be retiring from his position with the Company.
Max materiality 0.85 · Median 0.55 · Most common event earnings